Investors Management Corporation (IMC), a privately held company that strives to be a responsible owner of businesses that make a positive impact on others, named Jennifer Moses as Chief Financial Officer.
Prior to joining IMC in 2023, she was Chief Financial Officer at G1 Therapeutics. There she was responsible for SEC reporting, financing planning and analysis, and treasury. Previously, Jen was a partner at Rankin McKenzie, LLC, where she served as acting chief financial officer and controller for venture-backed companies. Before joining Rankin McKenzie, Jen held roles of increasing responsibility at Deloitte, including providing tax services to clients and later focusing on strategic planning and internal communications in the Office of the Chief Executive Officer of Deloitte Tax.
Jen serves on the Board of Directors of Viridian Therapeutics, Inc. She received her B.S. in Accounting from The Pennsylvania State University.
Learn more about Jennifer Moses and Investors Management Corporation here.
ON Partners partner Tim Conti is proud to have partnered with Investors Management Corporation on this chief financial officer search. Review more of our executive search placements in our Executive Talent Report.
Investors Management Corporation (IMC) is a privately held company that strives to be a responsible owner of businesses that make a positive impact on others. We aspire to grow our family of companies by partnering with organizations that share a common ethos. Regardless of the industry, IMC and our partner companies are united by our people-first approach and commitment to true partnership. Building meaningful relationships where we can learn and grow together sets a strong foundation for living out our 100-year plan.
To learn more about partnering with our executive search firm, meet our executive search consultants.